But research on cannabis is tough from the U.S. because of strict rules. Mainly because it's nonetheless a Routine I drug, experts will have to stick to DEA regulations or deal with fines. Like CBD, CBN doesn’t make a large. It's got similar results on your brain as CBD, while f